PaxMedica (PXMD) Stock Price, News & Analysis
What Changed
Price Move History
- Daily moves over 5%
- 41 103 sessions, August 29, 2025 to September 9, 2026
- Largest daily move
- +4900% close of October 30, 2025
- 1-year change
- +150% closing prices, August 29, 2025 to September 9, 2026
Company Description
PaxMedica (OTC Link: PXMD) is classified in the biotechnology industry within the Pharmaceutical Preparations sector.
PXMD has gained 150.0% over the past year. The last closing price was $0.0005.
For FY2023, PaxMedica reported revenue of $0 with net income of -$18.3M and diluted earnings per share of -$11.00.
This page collects what Stock Titan holds for PXMD, including price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
PaxMedica (PXMD) closed at $0.0005 on September 9, 2026. Over the past 12 months, the price has gained 150.0%.
PXMD Metrics & Rankings
Price returns through September 9, 2026. Month-to-date and YTD include the first trading day. Ranking links may use different dates.
Latest News
PaxMedica has 10 recent news articles. Of the recent coverage, 4 articles coincided with positive price movement and 6 with negative movement. Key topics include offering, fda approval. View all PXMD news →
SEC Filings
PaxMedica has filed 1 recent SEC filing, including 1 Form 10-Q. The most recent filing was submitted on January 14, 2026. SEC filings provide transparency into a company's financial condition, material events, and regulatory compliance. View all PXMD SEC filings →
Financial Highlights
operating income reached -$16.1M, and net income was -$18.3M. Diluted earnings per share stood at -$11.00. The company generated -$10.8M in operating cash flow. With a current ratio of 3.16, the balance sheet reflects a strong liquidity position.
Upcoming Events
Short Interest History
Short interest in PaxMedica (PXMD) currently stands at 687 shares, representing 0.0% of the float. This relatively low short interest suggests limited bearish sentiment.
Days to Cover History
Days to cover for PaxMedica (PXMD) currently stands at 1.0 days. This low days-to-cover ratio indicates high liquidity, allowing short sellers to quickly exit positions if needed. The days to cover has decreased 60.6% over the past year, suggesting improved liquidity for short covering. The ratio has shown significant volatility over the period, ranging from 1.0 to 5.5 days.
PXMD Company Profile & Sector Positioning
PaxMedica (PXMD) operates in the Biotechnology industry within the broader Pharmaceutical Preparations sector and is listed on the OTC Link.
Investors comparing PXMD often look at related companies in the same sector, including Biostax Corp (BTAX), Aridis Pharmaceuticals Inc (ARDS), Navidea Biopharm (NAVB), Virpax Pharmaceuticals Inc (VRPX), and Syros Pharmaceut (SYRS). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate PXMD's relative position within its industry.